Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elocon ointment with occlusive dressing versus Elocon alone in children with atopic dermatitis
2005-003806-27Phase 4Unknown
- Sponsor
- Princess Alexandra Hospital
- Start
- Aug 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mometasone in atopic dermatitis (AD) (2 arms), sponsored by Princess Alexandra Hospital. Primary endpoints: Resolution of atopic dermatitis patches and Local side effects. Status: unknown.
02
Drugs
mometasone
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2005-003806-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003806-27.